Philadelphia Woman Files Lawsuit Over Alleged Lipitor Diabetes

A Philadelphia woman is suing the manufacturers of the cholesterol drug Lipitor after she allegedly developed diabetes as a result of taking the drug.

According to the Pennsylvania Record, Doris Brown alleges that she developed Type 2 diabetes after she began cholesterol treatment with the drug Lipitor in 2009. Brown said that she was prescribed the drug to reduce her chances at developing heart disease.

In 2011, Brown developed Type 2 diabetes. Brown claims in her lawsuit that prior to taking Lipitor, she was physically active and had a healthy diet, with a total body mass index of about 20.1. Brown claims that Pfizer, Lipitor’s manufacturer, did not properly disclose the risks of the drug. She is seeking damages for pain and suffering and compensation for treatment.

Lipitor is a HMG-CoA reductase inhibitor that works by preventing an enzyme in the liver from creating low-density lipids. Lipitor has been linked to Type 2 diabetes in women. Recently, the US Food and Drug Administration (FDA) ordered Pfizer to change the drug’s label, adding a warning that it may increase HbA1c and fasting serum glucose levels.

People who suffer from Type 2 diabetes require extensive and expensive medical treatment. Contact our injury lawyers toll free at (888) 841-9623 if you have experienced negative side effects of Lipitor. Our firm offers confidential, no obligation consultations.

Zoll, Kranz & Borgess, LLC – Pharmaceutical Drug and Device Litigation Lawyers

Leave a Comment